Accelerating early-stage cell therapy development: critical considerations for analytical quality and comparability
04 Nov 2026
Cell Therapy Development
- Early analytical development and method validation strategies to ensure long-term clinical success
- Establishing robust comparability frameworks during early-stage process changes and site transfers
- Defining Critical Quality Attributes (CQAs) early in development to streamline regulatory submissions
- Overcoming early development bottlenecks to accelerate
